Evidence map›Paper›PMID 25743452›Full record

ReviewBest practice & research. Clinical gastroenterology2015

Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.

Hiroshi Nakagawa, Kelly Whelan, John P Lynch

Open access · greenAbstract readReview
In one paragraph

Review in Best practice & research. Clinical gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Esophageal organoids: applications and future prospects.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  3. Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hiroshi NakagawaDivision of Gastroenterology, 421 Curie Boulevard, 956 Biomedical Research Building, Philadelphia, PA, 19104, USA. Electronic address: nakagawh@mail.med.upenn.edu.
Kelly WhelanDivision of Gastroenterology, 421 Curie Boulevard, 956 Biomedical Research Building, Philadelphia, PA, 19104, USA. Electronic address: whelank@mail.med.upenn.edu.
John P LynchDivision of Gastroenterology, 421 Curie Boulevard, 956 Biomedical Research Building, Philadelphia, PA, 19104, USA. Electronic address: lynchj@mail.med.upenn.edu.
Philadelphia University · USUniversity of Pennsylvania · US

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUSTGI, ANIL K · 2003 to 2023
$31.7M
Weight loss-induced Microbiome and Adipokine Changes in Barrett's EsophagusU54CA163004 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ABRAMS, JULIAN, RUSTGI, ANIL K · 2011 to 2022
$12.5M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
The Intestinal Stem Cell NicheU01DK085551 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LYNCH, JOHN P., RUSTGI, ANIL K · 2009 to 2014
$2.1M
Modeling oxidative stress and DNA damage using GI organotypic culture systemsU18TR000536 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI LYNCH, JOHN P. · 2012 to 2013
$821k
Mouse models for esophageal Cox-2 oxidative stress and DNA damageK26OD012097 · OD · UNIVERSITY OF PENNSYLVANIA · PI LYNCH, JOHN P. · 2013 to 2017
$737k
Integrative mouse pathobiology: GI epithelial biology and geneticsK26OD011179 · OD · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2012 to 2015
$402k
NCATS NIH HHS TR 000536NCATS NIH HHS U18 TR000536NCI NIH HHS P01 CA098101NCI NIH HHS U54 CA163004NIDDK NIH HHS DK 085551NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK050306NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK085551NIDDK NIH HHS U24 DK085532NIH HHS K26 OD011179NIH HHS K26 OD012097
6 · The paper itself

Abstract

Barrett's oesophagus (BE) is defined as any metaplastic columnar epithelium in the distal oesophagus which replaces normal squamous epithelium and which predisposes to cancer development. It is this second requirement, the predisposition to cancer, which makes this condition both clinically highly relevant and an important area for ongoing research. While BE has been defined pathologically since the 1950's (Allison and Johnstone, Thorax 1955), and identified as a risk factor for esophageal adenocarcinoma since the 1970's (Naef A.P., et al J Thorac Cardiovasc Surg. 1975), our understanding of the molecular events giving rise to this condition remains limited. Herein we will examine what is known about the intestinal features of BE and how well it recapitulates the intestinal epithelium, including stem identity and function. Finally, we will explore laboratory models of this condition presently in use and under development, to identify new insights they may provide into this important clinical condition.

Indexed as

AdenocarcinomaAnimalsBarrett EsophagusEsophageal NeoplasmsHumansIntestinal MucosaPrecancerous ConditionsRisk FactorsStem Cells(3-10) gastroesophageal reflux disease (GERD)Barrett's oesophagus (BE)BMP4Cdx2Esophageal adenocarcinoma (EAC)HedgehogHuman 3D organotypic model systems (OTC)Multi-layered epithelium (MLE)Sox2Tissue engineering

Identifiers

PMID25743452
PMCPMC4352719
OpenAlexW2040970182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.